• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过自诱导在大肠杆菌中表达人可溶性环氧化物水解酶以用于高通量抑制测定的研究。

Expression of the human soluble epoxide hydrolase in Escherichia coli by auto-induction for the study of high-throughput inhibition assays.

作者信息

Nishi Kosuke, Kim In-Hae, Ma Seung-Jin

机构信息

Industry and Academic Cooperation Laboratory for Drug Development, Mokpo National University, Muan, Jeonnam 534-729, South Korea.

出版信息

Protein Expr Purif. 2010 Jan;69(1):34-8. doi: 10.1016/j.pep.2009.09.013. Epub 2009 Sep 25.

DOI:10.1016/j.pep.2009.09.013
PMID:19782755
Abstract

Soluble epoxide hydrolase (sEH) is a key enzyme involved in the metabolism of epoxy fatty acid mediators such as epoxyeicosatrienoic acids with emerging roles in the regulations of hypertension and inflammation. Inhibitors of human sEH (hsEH) are effective drug candidates for the treatment of cardiovascular diseases. Preparation of hsEH for enzyme inhibition studies has been carried out by using baculovirus expression system. We herein explored the feasibility of expression of hsEH in Escherichia coli cells for the study of high-throughput screening assays of enzyme inhibitors, because the bacterial expression system is easier to handle and more cost-effective than the baculovirus expression system. The functional target enzyme was successfully produced in prokaryotic expression system by an auto-induction method and exhibited comparable enzyme activity to that yielded in baculovirus expression system. The bacterial-hsEH showed similar sensitivity to the baculovirus-hsEH against six reported inhibitors. Overalls indicate that bacterial expression of hsEH employed in the present study is useful for preparing enzymatically active hsEH, leading to effective performance of high-throughput screening assay of hsEH inhibitors and to rapid identification of novel drug candidates for the treatment of cardiovascular diseases.

摘要

可溶性环氧化物水解酶(sEH)是参与环氧脂肪酸介质(如环氧二十碳三烯酸)代谢的关键酶,在高血压和炎症调节中发挥着新作用。人sEH(hsEH)抑制剂是治疗心血管疾病的有效候选药物。利用杆状病毒表达系统进行了用于酶抑制研究的hsEH的制备。我们在此探讨了在大肠杆菌细胞中表达hsEH用于酶抑制剂高通量筛选测定研究的可行性,因为细菌表达系统比杆状病毒表达系统更易于操作且成本效益更高。通过自动诱导方法在原核表达系统中成功产生了功能性靶酶,其表现出与杆状病毒表达系统中产生的酶活性相当的酶活性。细菌hsEH对六种已报道的抑制剂显示出与杆状病毒hsEH相似的敏感性。总体而言,本研究中采用的hsEH细菌表达对于制备具有酶活性的hsEH是有用的,从而能够有效地进行hsEH抑制剂的高通量筛选测定,并快速鉴定用于治疗心血管疾病的新型候选药物。

相似文献

1
Expression of the human soluble epoxide hydrolase in Escherichia coli by auto-induction for the study of high-throughput inhibition assays.通过自诱导在大肠杆菌中表达人可溶性环氧化物水解酶以用于高通量抑制测定的研究。
Protein Expr Purif. 2010 Jan;69(1):34-8. doi: 10.1016/j.pep.2009.09.013. Epub 2009 Sep 25.
2
[High-throughput screening of human soluble epoxide hydrolase inhibitors].[人可溶性环氧化物水解酶抑制剂的高通量筛选]
Yao Xue Xue Bao. 2010 Nov;45(11):1367-72.
3
Expression, purification, and characterisation of human soluble Epoxide Hydrolase (hsEH) and of its functional C-terminal domain.人可溶性环氧化物水解酶(hsEH)及其功能性C末端结构域的表达、纯化与表征
Protein Expr Purif. 2019 Jan;153:105-113. doi: 10.1016/j.pep.2018.09.001. Epub 2018 Sep 12.
4
Bacterial Expression and HTS Assessment of Soluble Epoxide Hydrolase Phosphatase.可溶性环氧化物水解酶磷酸酶的细菌表达及高通量筛选评估
J Biomol Screen. 2016 Aug;21(7):689-94. doi: 10.1177/1087057116637609. Epub 2016 Mar 23.
5
Polymorphisms in human soluble epoxide hydrolase.人类可溶性环氧化物水解酶的多态性
Mol Pharmacol. 2003 Aug;64(2):482-90. doi: 10.1124/mol.64.2.482.
6
Cardiovascular therapeutic aspects of soluble epoxide hydrolase inhibitors.可溶性环氧化物水解酶抑制剂的心血管治疗方面
Cardiovasc Drug Rev. 2006 Summer;24(2):169-88. doi: 10.1111/j.1527-3466.2006.00169.x.
7
Inhibition of soluble epoxide hydrolase by extracts derived from inflammation-treating Chinese medicinal herbs.抗炎中药提取物对可溶性环氧化物水解酶的抑制作用。
Phytother Res. 2008 Sep;22(9):1264-8. doi: 10.1002/ptr.2326.
8
A visible wavelength spectrophotometric assay suitable for high-throughput screening of 3-hydroxy-3-methylglutaryl-CoA synthase.一种适用于高通量筛选 3-羟基-3-甲基戊二酰辅酶 A 合酶的可见波长分光光度测定法。
Anal Biochem. 2010 Jan 1;396(1):96-102. doi: 10.1016/j.ab.2009.08.030. Epub 2009 Aug 23.
9
Measurement of soluble epoxide hydrolase (sEH) activity.可溶性环氧化物水解酶(sEH)活性的测定。
Curr Protoc Toxicol. 2007;Chapter 4:Unit 4.23. doi: 10.1002/0471140856.tx0423s33.
10
Structure-based optimization of arylamides as inhibitors of soluble epoxide hydrolase.基于结构的芳基酰胺作为可溶性环氧化物水解酶抑制剂的优化
J Med Chem. 2009 Oct 8;52(19):5880-95. doi: 10.1021/jm9005302.

引用本文的文献

1
Expression, purification, and characterisation of human soluble Epoxide Hydrolase (hsEH) and of its functional C-terminal domain.人可溶性环氧化物水解酶(hsEH)及其功能性C末端结构域的表达、纯化与表征
Protein Expr Purif. 2019 Jan;153:105-113. doi: 10.1016/j.pep.2018.09.001. Epub 2018 Sep 12.
2
Structure-activity relationships of substituted oxyoxalamides as inhibitors of the human soluble epoxide hydrolase.取代氧代草酰胺作为人可溶性环氧化物水解酶抑制剂的构效关系
Bioorg Med Chem. 2014 Feb 1;22(3):1163-75. doi: 10.1016/j.bmc.2013.12.027. Epub 2014 Jan 3.
3
Efficient E. coli expression strategies for production of soluble human crystallin ALDH3A1.
高效大肠杆菌表达策略生产可溶性人晶状体醛脱氢酶 3A1。
PLoS One. 2013;8(2):e56582. doi: 10.1371/journal.pone.0056582. Epub 2013 Feb 22.
4
Structure-activity relationships of cycloalkylamide derivatives as inhibitors of the soluble epoxide hydrolase.作为可溶性环氧化物水解酶抑制剂的环烷基酰胺衍生物的构效关系。
J Med Chem. 2011 Mar 24;54(6):1752-61. doi: 10.1021/jm101431v. Epub 2011 Feb 21.